Yagasaki Fumiharu

ヤガサキフミハル | Yagasaki Fumiharu

Research theme for competitive and other funds (2)：

2007 - 白血病の遺伝学的解析に基づく発症機序および至適治療法に関する研究
2004 - 2006 骨髄異形成症候群における染色体メチル化プロファイリング

MISC (31)：

Hayato Tamai, Hiroki Yamaguchi, Hiroyuki Hamaguchi, Fumiharu Yagasaki, Masami Bessho, Takeshi Kobayashi, Hideki Akiyama, Hisashi Sakamaki, Satoshi Takahashi, Arinobu Tojo, et al. Clinical features of adult acute leukemia with 11q23 abnormalities in Japan: a co-operative multicenter study. INTERNATIONAL JOURNAL OF HEMATOLOGY. 2008. 87. 2. 195-202
Hayato Tamai, Hiroki Yamaguchi, Hiroyuki Hamaguchi, Fumiharu Yagasaki, Masami Bessho, Takeshi Kobayashi, Hideki Akiyama, Hisashi Sakamaki, Satoshi Takahashi, Arinobu Tojo, et al. Clinical features of adult acute leukemia with 11q23 abnormalities in Japan: a co-operative multicenter study. INTERNATIONAL JOURNAL OF HEMATOLOGY. 2008. 87. 2. 195-202
Masamitsu Yanada, An Takeuchi, Isamu Sugiura, Hideki Akiyama, Noriko Usui, Fumiharu Yagasaki, Kazuhiro Nishii, Yasunori Ueda, Makoto Takeuchi, Shuichi Miyawaki, et al. Karyotype at diagnosis is the major prognostic factor predicting relapse-free survival for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with imatinib-combined chemotherapy. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL. 2008. 93. 2. 287-290
Masamitsu Yanada, An Takeuchi, Isamu Sugiura, Hideki Akiyama, Noriko Usui, Fumiharu Yagasaki, Kazuhiro Nishii, Yasunori Ueda, Makoto Takeuchi, Shuichi Miyawaki, et al. Karyotype at diagnosis is the major prognostic factor predicting relapse-free survival for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with imatinib-combined chemotherapy. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL. 2008. 93. 2. 287-290
Ph陽性白血病-イマチニブ時代の治療戦略. Medical Practice (文光堂). 2007. 24. 11. 1982-86

ｍore...

Books (6)：

BCR-ABL変異の検査は、どの時点で行うべきか? また、Mutationが認められた場合の治療法は?
EBM血液疾患の治療2008-2009 2007
CMLの体内動態:CMLに対するimatinibの継続投与の必要性
Annual Review 血液 2007 2007
日本・中国MDS共同研究(進行状況報告)
特発性造血障害に関する調査研究平成17年度総括・分担研究報告書 2006
慢性骨髄性白血病急性転化の治療と問題
血液フロンティア 2005
急性リンパ性白血病治療の到達点と問題点
Modern Physician

ｍore...

Lectures and oral presentations (6)：

Proline-Rich Tyrosine Kinase-2 (PYK2): A New Target for the Treatment of Hematopoietic Neoplasms with TEL-FGFR3 Fusion or FGFR3 Active Mutation.
(The 49th Annual Meeting of the American Society of Hematology 2007)
CMLにおける貧血遷延の検討
(第69回日本血液学会・第49回日本臨床血液学会合同総会 2007)
all-trans retinoic acid投与中に良性頭蓋内圧亢進症を発症した急性前骨髄性白血病
(第69回日本血液学会・第49回日本臨床血液学会合同総会 2007)
5q-症候群より移行した樹状細胞性白血病
(第69回日本血液学会・第49回日本臨床血液学会合同総会 2007)
9q-単独異常を有したAML(M6)例
(第69回日本血液学会・第49回日本臨床血液学会合同総会 2007)

ｍore...

Work history (3)：

2007 - 2009 Saitama Medical University Faculty of Medicine
2002 - 2007 Saitama Medical University Internal Medicine (Hematology), Faculty of Medicine
Saitama Medical University Faculty of Medicine Lecturer

Association Membership(s) (1)：

臨床腫瘍学会

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page